XML 11 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Cash flows from operating activities    
Net income $ 143,908 $ 344,056
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 24,017 19,341
Amortization of deferred financing fees 255 266
Equity-based compensation 15,231 11,631
Deferred taxes (3,115) 3,581
Loss (gain) on disposal of property, plant, and equipment 145 (143)
Foreign currency transaction loss (184) 844
Loss on equity method investment 217 0
Change in assets and liabilities:    
Accounts receivable 39,340 42,847
Floor plan receivables (4,978) 0
Inventories 47,696 30,470
Other assets (10,756) (9,895)
Accounts payable (15,309) (52,663)
Accrued expenses and other liabilities (17,850) (26,291)
Net cash provided by operating activities 218,617 364,044
Cash flows from investing activities    
Additions to property, plant, and equipment (40,986) (38,177)
Cash paid for equity method investment (2,250) 0
Cash paid for investment in ECN common stock (78,858) 0
Cash paid for investment in ECN preferred stock (64,520) 0
Investment in floor plan loans (18,466) 0
Proceeds from floor plan loans 14,646 0
Acquisitions, net of cash acquired (284,545) (6,810)
Proceeds from disposal of property, plant, and equipment 556 224
Net cash used in investing activities (474,423) (44,763)
Cash flows from financing activities    
Changes in floor plan financing, net 4,474 (35,460)
Payments on long term debt (67) 0
Stock option exercises 506 596
Tax payments for equity-based compensation (983) (1,363)
Net cash provided by (used in) financing activities 3,930 (36,227)
Effect of exchange rate changes on cash and cash equivalents 2,330 (6,019)
Net (decrease) increase in cash and cash equivalents (249,546) 277,035
Cash and cash equivalents at beginning of period 747,453 435,413
Cash and cash equivalents at end of period $ 497,907 $ 712,448